"http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/67971504.1/ben/cvp/2011/00000009/00000003/art00001/2B441E673361E6131332845653A524BB09FD3CDCA3.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf" . "Bilianou, Helen" . . . "187234" . "Kov\u00E1\u0159, Jan" . "1"^^ . "Nordestgaard, Borge G" . "Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement" . . "An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is <2 mmol/l (<180 mg/dl). 3). For standardized postprandial testing, a single FTT meal should be given after an 8 h fast and should consist of 75 g of fat, 25 g of carbohydrates and 10 g of protein. 4). A single TG measurement 4 h after a FTT meal provides a good evaluation of the postprandial TG response. 5). Preferably, subjects with non-fasting TG levels of 1-2 mmol/l (89-180 mg/dl) should be tested with a FTT. 6). TG concentration <= 2.5 mmol/l (220 mg/dl) at any time after a FTT meal should be considered as a desirable postprandial TG response. 7). A higher and undesirable postprandial TG response could be treated by aggressive lifestyle modification (including nutritional supplementation) and/or TG lowering drugs like statins, fibrates and nicotinic acid."@en . . "13"^^ . . "1570-1611" . . "000290656600001" . "Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement"@en . "9" . . "An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is <2 mmol/l (<180 mg/dl). 3). For standardized postprandial testing, a single FTT meal should be given after an 8 h fast and should consist of 75 g of fat, 25 g of carbohydrates and 10 g of protein. 4). A single TG measurement 4 h after a FTT meal provides a good evaluation of the postprandial TG response. 5). Preferably, subjects with non-fasting TG levels of 1-2 mmol/l (89-180 mg/dl) should be tested with a FTT. 6). TG concentration <= 2.5 mmol/l (220 mg/dl) at any time after a FTT meal should be considered as a desirable postprandial TG response. 7). A higher and undesirable postprandial TG response could be treated by aggressive lifestyle modification (including nutritional supplementation) and/or TG lowering drugs like statins, fibrates and nicotinic acid." . "Panotopoulos, George" . . . "AE - St\u00E1t Spojen\u00E9 arabsk\u00E9 emir\u00E1ty" . . "Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement" . . "Kolovou, Genovefa D" . "Lairon, Dennis" . . "Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement"@en . "Postprandial triglycerides; non-fasting triglycerides; chylomicron remnants; very low density lipoprotein remnants; fat tolerance test; cardiovascular disease"@en . . "Anagnostopoulou, Katherine" . "Mikhailidis, Dimitri P" . . "Current vascular pharmacology" . . "RIV/00023001:_____/11:00002449!RIV12-MZ0-00023001" . . "10"^^ . . "Perez-Martinez, Pablo" . "N" . "RIV/00023001:_____/11:00002449" . "[BDE5EB4DD279]" . "3" . . "Ooi, Teik Chye" .